ArticleBreast cancer research and treatment2023

A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).

Monica K Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.